Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Layna Brantner

Nurse Practitioner, Psychiatric/Mental Health Branson, MO Nurse Practitioner

NPI 1811659683 CMS profile 11277353

500 W Main St Ste 204, Branson, MO 65616

Open in the dashboard

General payments

$10,061

415 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Layna Brantner of Branson, MO is reported in the CMS Open Payments database as having received $10,061 across 415 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,991 121
2024 General $2,744 107
2023 General $2,955 134
2022 General $1,269 52
2021 General $102 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Layna Brantner
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Layna Brantner were reported at $2,991. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Layna Brantner Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $102 $166 $54–$482 $132
2022 $1,269 $195 $66–$559 $149
2023 $2,955 $233 $82–$673 $160
2024 $2,744 $236 $84–$688 $164
2025 $2,991 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Axsome Therapeutics, Inc. $1,250 47 payments
  2. AbbVie, Inc. $1,076 38 payments
  3. Neurocrine Biosciences, Inc. $889 33 payments
  4. Vanda Pharmaceuticals Inc. $841 35 payments
  5. Alkermes, Inc. $797 25 payments
  6. ITI, Inc. $753 36 payments
  7. Otsuka America Pharmaceutical, Inc. $749 36 payments
  8. Teva Pharmaceuticals USA, Inc. $740 31 payments
  9. Corium, Inc. $578 32 payments
  10. E.R. Squibb & Sons, L.L.C. $439 20 payments
  11. Other $1,949 82 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $9,938 411 payments
  2. Education $122 4 payments
Products named General payments · program years 2021–2025
  1. Auvelity $1,113 41 payments
  2. INGREZZA $889 33 payments
  3. FANAPT $841 35 payments
  4. LYBALVI $795 24 payments
  5. VRAYLAR $685 28 payments
  6. HETLIOZ $648 31 payments
  7. ARISTADA Cns $585 23 payments
  8. ARISTADA Cns $585 23 payments
  9. Azstarys $578 32 payments
  10. ARISTADA Cns $567 22 payments
  11. Other $6,553 258 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

415 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record